179 related articles for article (PubMed ID: 27418017)
1. Potential of quantitative susceptibility mapping for detection of prostatic calcifications.
Straub S; Laun FB; Emmerich J; Jobke B; Hauswald H; Katayama S; Herfarth K; Schlemmer HP; Ladd ME; Ziener CH; Bonekamp D; Röthke MC
J Magn Reson Imaging; 2017 Mar; 45(3):889-898. PubMed ID: 27418017
[TBL] [Abstract][Full Text] [Related]
2. Detecting prostate cancer and prostatic calcifications using advanced magnetic resonance imaging.
Dou S; Bai Y; Shandil A; Ding D; Shi D; Haacke EM; Wang M
Asian J Androl; 2017; 19(4):439-443. PubMed ID: 27004542
[TBL] [Abstract][Full Text] [Related]
3. Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping.
Chen W; Zhu W; Kovanlikaya I; Kovanlikaya A; Liu T; Wang S; Salustri C; Wang Y
Radiology; 2014 Feb; 270(2):496-505. PubMed ID: 24126366
[TBL] [Abstract][Full Text] [Related]
4. Delineation of prostatic calcification using quantitative susceptibility mapping: Spatial accuracy for magnetic resonance-only radiotherapy planning.
Kan H; Tsuchiya T; Yamada M; Kunitomo H; Kasai H; Shibamoto Y
J Appl Clin Med Phys; 2022 Feb; 23(2):e13469. PubMed ID: 34726833
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH
J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519
[TBL] [Abstract][Full Text] [Related]
6. Mask-Adapted Background Field Removal for Artifact Reduction in Quantitative Susceptibility Mapping of the Prostate.
Straub S; Emmerich J; Schlemmer HP; Maier-Hein KH; Ladd ME; Röthke MC; Bonekamp D; Laun FB
Tomography; 2017 Jun; 3(2):96-100. PubMed ID: 30042974
[TBL] [Abstract][Full Text] [Related]
7. Joint 2D and 3D phase processing for quantitative susceptibility mapping: application to 2D echo-planar imaging.
Wei H; Zhang Y; Gibbs E; Chen NK; Wang N; Liu C
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26887812
[TBL] [Abstract][Full Text] [Related]
8. Detection of prostate calcification with megavoltage helical CT.
Hama Y
Acad Radiol; 2014 May; 21(5):565-8. PubMed ID: 24703468
[TBL] [Abstract][Full Text] [Related]
9. Quantitative susceptibility mapping (QSM) as a means to monitor cerebral hematoma treatment.
Zhang Y; Wei H; Sun Y; Cronin MJ; He N; Xu J; Zhou Y; Liu C
J Magn Reson Imaging; 2018 Oct; 48(4):907-915. PubMed ID: 29380461
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of iliofemoral peripheral vascular calcifications using proton density-weighted, in-phase three-dimensional stack-of-stars gradient echo.
Ferreira Botelho MP; Koktzoglou I; Collins JD; Giri S; Carr JC; Gupta N; Edelman RR
Magn Reson Med; 2017 Jun; 77(6):2146-2152. PubMed ID: 27297954
[TBL] [Abstract][Full Text] [Related]
11. Rapid quantitative T
Dregely I; Margolis DA; Sung K; Zhou Z; Rangwala N; Raman SS; Wu HH
Magn Reson Med; 2016 Dec; 76(6):1720-1729. PubMed ID: 26765746
[TBL] [Abstract][Full Text] [Related]
12. Assessment of intracranial meningioma-associated calcifications using susceptibility-weighted MRI.
Adams LC; Böker SM; Bender YY; Fallenberg EM; Wagner M; Buchert R; Hamm B; Makowski MR
J Magn Reson Imaging; 2017 Oct; 46(4):1177-1186. PubMed ID: 28106942
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of using a single MRI acquisition for fiducial marker localization and synthetic CT generation towards MRI-only prostate radiation therapy treatment planning.
Nosrati R; Lam WW; Paudel M; Pejović-Milić A; Morton G; Stanisz GJ
Biomed Phys Eng Express; 2021 Jun; 7(4):. PubMed ID: 34034242
[No Abstract] [Full Text] [Related]
14. Black Dipole or White Dipole: Using Susceptibility Phase Imaging to Differentiate Cerebral Microbleeds from Intracranial Calcifications.
Weng CL; Jeng Y; Li YT; Chen CJ; Chen DY
AJNR Am J Neuroradiol; 2020 Aug; 41(8):1405-1413. PubMed ID: 32675335
[TBL] [Abstract][Full Text] [Related]
15. Rapid automated liver quantitative susceptibility mapping.
Jafari R; Sheth S; Spincemaille P; Nguyen TD; Prince MR; Wen Y; Guo Y; Deh K; Liu Z; Margolis D; Brittenham GM; Kierans AS; Wang Y
J Magn Reson Imaging; 2019 Sep; 50(3):725-732. PubMed ID: 30637892
[TBL] [Abstract][Full Text] [Related]
16. Calcifications are potential surrogates for prostate localization in image-guided radiotherapy.
Zeng GG; McGowan TS; Larsen TM; Bruce LM; Moran NK; Tsao JR; MacPherson MS
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):963-6. PubMed ID: 18954708
[TBL] [Abstract][Full Text] [Related]
17. Potential applications of the quantitative susceptibility mapping (QSM) in MR-guided radiation therapy.
Nosrati R; Paudel M; Ravi A; Pejovic-Milic A; Morton G; Stanisz GJ
Phys Med Biol; 2019 Jul; 64(14):145013. PubMed ID: 31151120
[TBL] [Abstract][Full Text] [Related]
18. Investigating hyperoxic effects in the rat brain using quantitative susceptibility mapping based on MRI phase.
Hsieh MC; Kuo LW; Huang YA; Chen JH
Magn Reson Med; 2017 Feb; 77(2):592-602. PubMed ID: 26834053
[TBL] [Abstract][Full Text] [Related]
19. Projection MR imaging of peripheral arterial calcifications.
Edelman RR; Flanagan O; Grodzki D; Giri S; Gupta N; Koktzoglou I
Magn Reson Med; 2015 May; 73(5):1939-45. PubMed ID: 24957402
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Susceptibility Mapping for Following Intracranial Hemorrhage.
Sun H; Klahr AC; Kate M; Gioia LC; Emery DJ; Butcher KS; Wilman AH
Radiology; 2018 Sep; 288(3):830-839. PubMed ID: 29916778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
